References
- 1. Frangogiannis NG. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol. 2014;63:185-195. doi: 10.1097/FJC.0000000000000003.10.1097/FJC.0000000000000003394916324072174
- 2. Ruparelia N, Godec J, Lee R, et al. Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humans. Eur Heart J. 2015;36:1923-1934. doi: 10.1093/ eurheartj/ehv195.10.1093/eurheartj/ehv195457117725982896
- 3. Lugrin J, Parapanov R, Rosenblatt-Velin N, et al. Cutting edge: IL-1α is a crucial danger signal triggering acute myocardial inflammation during myocardial infarction. J Immunol. 2015;194:499-503. doi: 10.4049/jimmunol.1401948.10.4049/jimmunol.1401948427819625505286
- 4. Kain V, Prabhu SD, Halade GV. Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res Cardiol. 2014;109:444. doi: 10.1007/s00395-014-0444-7.10.1007/s00395-014-0444-725248433
- 5. Nguyen TL, Phan JA, Hee L, et al. High-sensitivity troponin T predicts infarct scar characteristics and adverse left ventricular function by cardiac magnetic resonance imaging early after reperfused acute myocardial infarction. Am Heart J. 2015;170:715-725.e2. doi: 10.1016/j.ahj.2015.06.022.10.1016/j.ahj.2015.06.02226386795
- 6. Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 2016;119:91-112. doi: 10.1161/ CIRCRESAHA.116.303577.10.1161/CIRCRESAHA.116.303577492252827340270
- 7. Groot HE, Hartman MH1, Gu YL, et al. Soluble interleukin 6 receptor levels are associated with reduced myocardial reperfusion after percutaneous coronary intervention for acute myocardial infarction. Cytokine. 2015;73:207-212. doi: 10.1016/j.cyto.2015.02.004.10.1016/j.cyto.2015.02.00425792278
- 8. Puhakka M, Magga J, Hietakorpi S, et al. Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. J Card Fail. 2003;9:325-332. doi: 10.1054/jcaf.2003.38.10.1054/jcaf.2003.3813680554
- 9. Müller J, Gorressen S, Grandoch M, et al. Interleukin-6- dependent phenotypic modulation of cardiac fibroblasts after acute myocardial infarction. Basic Res Cardiol. 2014;109:440. doi: 10.1007/s00395-014-0440-y.10.1007/s00395-014-0440-y25236954
- 10. Takahashi T, Anzai T, Kaneko H, et al. Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol. 2010;299:H1795-H1804. doi: 10.1152/ ajpheart.00001.2010.10.1152/ajpheart.00001.201020852043
- 11. Zhang R, Zhang YY, Huang XR, et al. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. Hypertension. 2010;55:953-960. doi: 10.1161/HYPERTENSIONAHA.109.140608.10.1161/HYPERTENSIONAHA.109.14060820157054
- 12. Ribeiro DR, Ramos AM, Vieira PL, et al. High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction. Arq Bras Cardiol. 2014;103:69-75.10.5935/abc.20140086412676325120085
- 13. Reinstadler SJ, Thiele H, Eitel I. Risk stratification by cardiac magnetic resonance imaging after ST-elevation myocardial infarction. Curr Opin Cardiol. 2015;30:681-689. doi: 10.1097/ HCO.0000000000000227.10.1097/HCO.000000000000022726398412
- 14. Sadahiro T, Kohsaka S, Okuda S, et al. MRI and serum highsensitivity C reactive protein predict long-term mortality in non-ischaemic cardiomyopathy. Open Heart. 2015;2:e000298. doi: 10.1136/openhrt-2015-000298.10.1136/openhrt-2015-000298462022926512328
- 15. Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015;36:482-489. doi:10.1093/eurheartj/ehu403.10.1093/eurheartj/ehu403434036425433021
- 16. Xu S, Song M, Xiong Y, Liu X, He Y, Qin Z. The association between periodontal disease and the risk of myocardial infarction: a pooled analysis of observational studies. BMC Cardiovascular Disorders. 2017;17:50. doi:10.1186/s12872-017- 0480-y.10.1186/s12872-017-0480-y528686228143450
- 17. Sincar CD, Ioanid N, Rudnic I, et al. The biochemical effects of non-surgical periodontal therapy in patients with and without chronic renal disease. Revista de Chimie. 2017;68:605-607.10.37358/RC.17.3.5511
- 18. Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. Journal of Internal Medicine. 2015;278:483-493. doi:10.1111/joim.12406.10.1111/joim.12406508211126260307
- 19. Suleiman M, Khatib R, Agmon Y et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol. 2006;47:962-968. doi: 10.1016/j.jacc.2005.10.05510.1016/j.jacc.2005.10.05516516078
- 20. Karpiński L, Płaksej R, Kosmala W, Witkowska M. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty. Kardiol Pol. 2008;66:1279-1285.10.20452/pamw.624
- 21. Ritschel VN, Seljeflot I, Arnesen H, et al. IL-6 signalling in patients with acute ST-elevation myocardial infarction. Results Immunol. 2013;4:8-13. doi: 10.1016/j.rinim.2013.11.002.10.1016/j.rinim.2013.11.002397382124707455
- 22. Roes SD, Kelle S, Kaandorp TA, et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol. 2007;100:930-936. doi: 10.1016/j. amjcard.2007.04.029.10.1016/j.amjcard.2007.04.02917826372
- 23. Ørn S, Manhenke C, Ueland T, et al. C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. Eur Heart J. 2009;30:1180-1186. doi: 10.1093/eurheartj/ehp070.10.1093/eurheartj/ehp07019299430
- 24. Khan JN, McCann GP. Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction. World J Cardiol. 2017;9:109-133. doi:10.4330/wjc. v9.i2.109.10.4330/wjc.v9.i2.109532973828289525
- 25. Rajewska-Tabor J, Pyda M, Kociemba A, Janus M, Lanocha M, Siniawski A. Influence of inflammatory response on infarct size and microvascular obstruction estimated by cardiac magnetic resonance in patients with ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2015;17(Suppl 1):P160.doi:10.1186/1532-429X-17-S1-P160.10.1186/1532-429X-17-S1-160
- 26. Fang L, Moore X-L, Dart AM, Wang L-M. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol. 2015;12:305-312. doi:10.11909/j.issn.1671-5411.2015.03.020.